For research and educational purposes only. Not medical advice.
Idebenone Reference
Educational, not medical advice reference for Idebenone: Nootropic, Metabolic; regulatory status, evidence posture, source review, and schedule notes. Also k…
Reference summary
EU Raxone label-verified evidence in LHON. Friedreich ataxia trials did not yield FDA approval. Smaller cognitive-impairment literature.
- Categories
- Nootropic, Metabolic
- Aliases
- Catena, Raxone, CV-2619
- Evidence posture
- human — Approved in the EU as Raxone for Leber's hereditary optic neuropathy. Not FDA-approved in the US. Friedreich ataxia trials did not advance.
- Regulatory status
- No FDA-approved idebenone drug label. Approved in the EU as Raxone for Leber's hereditary optic neuropathy (LHON). Sold as a dietary supplement in the US.
- Content review status
- research reference